Publication | Closed Access

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Advanced Cervical CancerCervical CancerCervical HealthMedicineMetronomic TherapyGynecologyPharmacotherapyCancer TreatmentOncologyRadiation OncologyGynecology OncologyHealth Sciences